Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WM-115 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 3780 | 251 | 0.9177 | 0.9211 | 0.0664 | 0.0646 |
WM-115 | Vemurafenib | I-BET151 | 0.316 | 0.000 | uM | 72 | hr | 3 | 2813 | 183 | 0.7538 | 0.7662 | 0.0651 | 0.0650 |
WM-115 | Vemurafenib | I-BET151 | 0.316 | 0.000 | uM | 72 | hr | 2 | 2905 | 193 | 0.7773 | 0.7662 | 0.0664 | 0.0650 |
WM-115 | Vemurafenib | I-BET151 | 0.316 | 0.000 | uM | 72 | hr | 1 | 2860 | 182 | 0.7676 | 0.7662 | 0.0636 | 0.0650 |
MZ7-mel | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 4690 | 306 | 0.9633 | 1.1499 | 0.0652 | 0.0651 |
MZ7-mel | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 6042 | 428 | 1.2336 | 1.1499 | 0.0708 | 0.0651 |
MZ7-mel | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 6060 | 359 | 1.2527 | 1.1499 | 0.0592 | 0.0651 |
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 1093 | 67 | 0.8186 | 0.7894 | 0.0613 | 0.0654 |
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 984 | 71 | 0.7285 | 0.7894 | 0.0722 | 0.0654 |
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 1098 | 69 | 0.8210 | 0.7894 | 0.0628 | 0.0654 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 3491 | 225 | 1.0652 | 1.0000 | 0.0645 | 0.0654 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 5915 | 430 | 0.2777 | 0.2714 | 0.0727 | 0.0654 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 3299 | 192 | 1.0134 | 1.0000 | 0.0582 | 0.0654 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 3049 | 224 | 0.9214 | 1.0000 | 0.0735 | 0.0654 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 5334 | 374 | 0.2512 | 0.2714 | 0.0701 | 0.0654 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 5949 | 318 | 0.2851 | 0.2714 | 0.0535 | 0.0654 |
WM-115 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 3619 | 242 | 0.8072 | 0.8216 | 0.0669 | 0.0659 |
WM-115 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 3649 | 235 | 0.8160 | 0.8216 | 0.0644 | 0.0659 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 2904 | 195 | 0.7044 | 0.7665 | 0.0671 | 0.0659 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 3246 | 205 | 0.7908 | 0.7665 | 0.0632 | 0.0659 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 3316 | 223 | 0.8043 | 0.7665 | 0.0672 | 0.0659 |
WM-115 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 3771 | 250 | 0.8416 | 0.8216 | 0.0663 | 0.0659 |
MZ7-mel | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 2847 | 207 | 0.5309 | 0.4729 | 0.0727 | 0.0666 |
MZ7-mel | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 2815 | 143 | 0.5373 | 0.4729 | 0.0508 | 0.0666 |
MZ7-mel | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 1886 | 144 | 0.3503 | 0.4729 | 0.0764 | 0.0666 |